Hemostatic Drug Less Effective Than Originally Predicted, Study Published in CMAJ
Medical News Today -- The use of recombinant activated factor 7 (rFVIIa) - a drug used to treat bleeding in hemophiliacs - in patients without hemophilia is not recommended because of the potential for adverse events, found a study published in CMAJ (Canadian Medical Association Journal).